Notice ID: f546a27f816b4b9892521e4748cf0991Combined Synopsis/Solicitation
Histopathology Services to Support On-going Small Animal Product Efficacy Studies for Viruses with Pandemic Potential
Archived on September 28, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM UTC−04:00
- Posted
- September 12, 2024
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 541940: Veterinary Services
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIAID
- Place of performance
- Bethesda, MD, 20892
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- RFQ-NIAID-24-2226993
- Notice ID
- f546a27f816b4b9892521e4748cf0991
Description
AMENDMENT 1 - 9/4/2024: Added RFQ Attachment 3 - QA with answers to vendor questions AMENDMENT 2 - 9/10/2024: Revised RFQ Attachment 3 - QA with answers to an additional vendor question AMENDMENT 3 - 9/11/2024: Revised RFQ Attachment 3 - QA to clarify an existing response to a vendor question. This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-24-2226993 and the solicitation is issued as a Request for Quotation (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2024-05 Effective May 22, 2024. The North American Industry Classification System (NAICS) code for this procurement is 541940 Veterinary Services with a size standard of $10M. The Product or Service Code (PSC) is Q301 Medical-Laboratory Testing. The requirement is being competed as full and open competition without a small business set-aside. The government intends to award a firm-fixed-price purchase order to the responsible offeror as a result of this RFQ that will include the terms and conditions set forth herein. By submitting a quote, the offeror is accepting that all government terms and condition shall prevail over the award. STATEMENT OF NEED The US Government has undertaken a broad effort to support the development of new products for use against viruses having the potential to cause future pandemics. As we saw during the SARS-CoV-2 pandemic, rapid response requires the use of small rodent infection models in which to evaluate promising candidate vaccines and therapeutics. Because one of the hallmarks of several viral infections is overt pathologic changes to infected tissues, representative images and a complete evaluation of affected tissue sections are critical to study outcomes and are often a necessary and critical component of product efficacy evaluations. Preparing stained slides from infected tissues, evaluating slides, and generating a report of observations is labor-intensive and frequently exceeds the capacity of contractors conducting the efficacy studies. Therefore, there is a bona fide need to support these product efficacy studies by engaging professional histopathology services. The Government seeks commercially available veterinary histopathology services to prepare hematoxylin and eosin (H&E) stained microscope slides from formalin-fixed tissue(s), evaluate and interpret the slides, capture photomicrographs of representative images and generate reports to meet the requirements of product efficacy testing for a base quantity of five (5) studies starting with prepared slides. Ten (10), one-study quantity options starting with prepared slides and five (5), one-study quantity options starting with fixed tissues are included in both the base period and Option Period 1. ESTIMATED PERIOD OF PERFORMANCE Base Period: September 23, 2024 September 22, 2025 Option Period 1: September 23, 2025 September 22, 2026 INSTRUCTIONS All interested vendors shall provide a quote for the requirement as outlined in Attachment 1 Statement of Work (SOW). Quotes must be no more than 15 pages long, excluding resumes. Quotes must include: Price(s) (unit price, total price) for all base and option quantities. Clear indication of the capability of the vendor to meet all specifications and requirements No more than three (3) references from within the last three (3) years indicating past performance of similar size and scope. Include organization name, point of contract information, and a brief description of the scope of the project. The Government may evaluate only those quotes that fully meet the requirements as outlined in the SOW and respond to the instructions and requirements below. Failure to furnish a full and complete quote as instructed may result in the Offerors response being considered non-responsive and will therefore be eliminated from further consideration and award. Any questions or concerns regarding this combined synopsis/solicitation are due by 3:00pm ET September 9, 2024 and must be emailed to Seth.Schaffer@nih.gov. Quotes are due by 3:00pm ET on September 13, 2024. Quotes must be emailed to Seth Schaffer, Contract Specialist, at Seth.Schaffer@nih.gov. Late quotes will not be considered. All responsible sources may submit an offer that will be considered by this Agency. EVALUATION NIAID will evaluate quotes to determine the best value to the government. NIAID will make that determination based on technical capability, past performance, and price. NIAID will evaluate past performance and price only for those quotes which are rated as technically capable. In the event quotes are evaluated as technically equal, past performance and price will become major considerations in selecting the successful Vendor. The Government will not award a purchase order to a Contractor at a significantly higher evaluated price to achieve only slightly superior performance capabilities. Likewise, the Government will not award to a Contractor simply because its quote is technically acceptable and also the lowest quoted price. The Government intends to award without discussions but reserves the right to conduct discussions should it be deemed in the Governments best interest. The Government will evaluate quotes for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that a quote is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s). SPECIAL NOTICE TO VENDORS Vendors are advised that the Government may share your information with non-government personnel who are assisting with the evaluation of quotes. The exclusive responsibility for source selection will reside with the Government. By submitting your quote, you will be consenting to disclosure of your quote to non-government personnel for purposes of evaluation. ELECTRONIC INVOICING The successful vendor may submit an invoice after providing deliverables for a study. NIAID will only accept invoices for deliverables that have been delivered to NIAID and inspected and accepted. NIH is using a phased transition approach from the NIH Office of Financial Management (OFM) Electronic Invoice Submission instructions to the Department of Treasurys Invoice Processing Platform (IPP). For contractors that have transitioned to IPP, the Contractor must submit invoices to the Department of Treasurys IPP at https://www.ipp.gov. For contractors that have not transitioned to IPP, the Contractor shall submit invoices to the NIH OFM via email at invoicing@nih.gov with a copy to the approving official until the Contractor has been notified of its transition to IPP. REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (SECTION 889) All offerors shall have current documentation showing representation of compliance with Section 889 provisions. Prior to award of delivery order resulting from solicitation, quoters shall be prepared to provide copy of section 889 compliance if requested by the Contracting Officer. SECTION 508 Section 508 of the Rehabilitation Act, as amended by the Workforce Investment Act of 1998 (P.L. 105-220) requires that when Federal agencies develop, procure, maintain, or use information and communication technology (ICT), it shall be accessible to people with disabilities. Federal employees and members of the public who have disabilities must have access to, and use of, information and data that is comparable to people without disabilities. Vendors must identify whether a quoted Information and Communication Technology (ICT) product or service is compliant with the Section 508 accessibility standards at 36 CFR 1194. The quote must also identify where full details of compliance can be found (e.g., vendor's website or other exact location.) For more information on Section 508 standards visit https://www.section508.gov/. PROVISIONS AND CLAUSES The following Federal Acquisition Regulation (FAR) provisions apply to this acquisition: FAR 52.252-1 Solicitation Provisions Incorporated by Reference (Feb 1998) This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at this/these address(es): https://www.acquistion.gov/ (End of provision) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements or Statements Representations (Jan 2017) FAR 52.204-7 - System for Award Management (Oct 2018) FAR 52.204-16 - Commercial for Government Entity Code Reporting (Aug 2020) FAR 52.204-24 - Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) FAR 52.209-7 - Information Regarding Responsibility Matters (Oct 2018) FAR 52.212-1 - Instructions to Offerors Commercial Products and Commercial Services (Sep 2023) FAR 52.212-3 - Offeror Representations and Certifications Commercial Products and Commercial Services (May 2024) FAR 52.217-5 Evaluation of Options (Jul 1990) Except when it is determined in accordance with FAR 17.206(b) not to be in the Governments best interests, the Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. Evaluation of options will not obligate the Government to exercise the option(s). (End of provision) The following Federal Acquisition Regulation (FAR) clauses apply to this acquisition: FAR 52.252-2 Clauses Incorporated By Reference (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es): https://www.acquistion.gov/ (End of clause) FAR 52.203-19 Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (Jan 2017) FAR 52.204-13 - System for Award Management Maintenance (Oct 2018) FAR 52.204-18 Commercial and Government Entity Code Maintenance (Aug 2020) FAR 52.204-21 - Basic Safeguarding of Covered Contractor Information Systems (Nov 2021) FAR 52.232-40 - Providing Accelerated Payments to Small Business and Subcontractors (Mar 2023) FAR 52.212-4 - Contract Terms and Conditions Commercial Products and Commercial Services (May 2024) FAR 52.212-5 - Contract Terms and Conditions Required to Implement Status or Executive Orders Statements Representation (May 2024) FAR 52.217-7 Option for Increased Quantity-Separately Priced Line Item (Mar 1989) The Government may require the delivery of the numbered line item, identified in the Schedule as an option item, in the quantity and at the price stated in the Schedule. The Contracting Officer may exercise the option by written notice to the Contractor within 14 days. Delivery of added items shall continue at the same rate that like items are called for under the contract, unless the parties otherwise agree. (End of clause) FAR 52.217-8 - Option to Extend Services (Nov 1999) The Government may require continued performance of any services within the limits and at the rates specified in the contract. These rates may be adjusted only as a result of revisions to prevailing labor rates provided by the Secretary of Labor. The option provision may be exercised more than once, but the total extension of performance hereunder shall not exceed 6 months. The Contracting Officer may exercise the option by written notice to the Contractor within 14 days. (End of clause) FAR 52.217-9 - Option to Extend the Term of the Contract (Mar 2000) (a) The Government may extend the term of this contract by written notice to the Contractor within 14 days; provided that the Government gives the Contractor a preliminary written notice of its intent to extend at least 14 days before the contract expires. The preliminary notice does not commit the Government to an extension. (b) If the Government exercises this option, the extended contract shall be considered to include this option clause. (c) The total duration of this contract, including the exercise of any options under this clause, shall not exceed 30 months. (End of clause) By reference the Department of Health and Human Services Acquisition Regulation (HHSAR) provisions and clauses that are applicable to this requirement: HHSAR 352.203-70 Anti-lobbying (Dec 2015) HHSAR 352.208-70 Printing and Duplication (Dec 2015) HHSAR 352.222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (Dec 2015) HHSAR 352.223-70 Safety and Health (Dec 2015) HHSAR 352.224-71 Confidential Information (Dec 2015) HHSAR 352.231-70 Salary Rate Limitation (Dec 2015) HHSAR 352.239-73 Electronic and Information Technology Accessibility Notice (Dec 2015) HHSAR 352.239-74 Electronic and Information Technology Accessibility (Dec 2015) By full text the Department of Health and Human Services Acquisition Regulation (HHSAR): HHSAR 352.232-71 - Electronic Submission of Payment Requests LIST OF ATTACHMENTS Attachment 1 Statement of Work (SOW) Attachment 2 - FAR 52.212-5 Contract Terms and Conditions Required to Implement Status or Executive Orders Statements Representation
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
RFQ-NIAID-24-2226993- Combined Synopsis
- 4×Combined SynopsisCurrentSep 3, 2024
Histopathology Services to Support On-going Small Animal Product Efficacy Studies for Viruses with Pandemic Potential
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Amendment 12639526Q0089-0001 and the revised Attachment 2 - Diagnostic Services Price List are uploaded to the "Attachments/Links" section. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12. This announcement constitutes the only solicitation. Quotations are being requested and a separate written solicitation will not be issued. Solicitation number 12639526Q0089 is issued as a Request for Quotation (RFQ) for diagnostic testing services from NAHLN approved laboratories. See Attachment 1 – Performance Work Statement for a complete list of requirements. This acquisition is not set-aside for small business concerns. The applicable North American Industry Classification Standard Code is 541940 Veterinary Services. The small business size standard is $10 million. This acquisition is being conducted under other than full and open competition; see Attachment 3 - Class Justification and Approval. All responsible sources may submit a quotation which will be considered by the agency. | 57% | Combined Synopsis | 06/16/2027 |
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01209/PCA-NIA-08501. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Epigenetic Clock Development Foundation 1124 W. Carson Street, MRL Bldg., 3rd Floor Torrance, CA 90502 US to provide obtain DNA methylation profiling and epigenetic age analysis for 320 previously extracted murine DNA samples using the Mammal320K methylation array and established Horvath epigenetic clock methodologies. | 46% | Combined Synopsis | 09/23/2026 |
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01212/PCA-NIA-08124. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Metabolon Inc. 617 Davis Drive, Suite 100, Morrisville, NC 27560 to assay global metabolomics data and short chain fatty acids (SCFA) via the Metabolon platform from 369 blood samples in the BLSA. These metabolomics data will be used to identify metabolomic signatures of anthropometric aging quantified via a 3D body scanner. | 46% | Combined Synopsis | 09/23/2026 |
Husbandry Animal Services | 42% | Market Research | 11/09/2026 |
Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services. | 39% | Market Research | 12/04/2026 |
Additional Details
Solicitation Number
RFQ-NIAID-24-2226993
Archive Date
Sep 28, 2024
Office Address
BETHESDA, MD, 20892